W.R. Berkley Corp’s Tevogen Inc. Common Stock TVGN Stock Holding History

W.R. Berkley Corp’s Portfolio TVGN Stock Details TVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,975	Closed	-$2.15M	–	207
2023 Q3	$2.15M	Buy	+3,975	New	+$2.14M	0.14%	112
2023 Q1	–	Sell	-8,489	Closed	-$4.38M	–	252
2022 Q4	$4.38M	Buy	8,489 +1,470	+21%	+$752K	0.24%	73
2022 Q3	$3.56M	Buy	7,019 +1,084	+18%	+$547K	0.17%	104
2022 Q2	$2.97M	Hold	5,935	–	–	0.15%	123
2022 Q1	$2.96M	Buy	+5,935	New	+$2.95M	0.15%	132

Other funds holding TVGN

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Centiva Capital New York $13.6B AUM 20% 1-Year Est. Return

WCMNY

Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

W.R. Berkley Corp's TVGN Position: Q4 2023 in Review

W.R. Berkley Corp sold out of Tevogen Inc. Common Stock (TVGN) in Q4 2023, closing a stake of 3,975 shares — an estimated $2.15M sold.

W.R. Berkley Corp first reported a position in TVGN in Q1 2022 and held it in 5 quarters. The position peaked at $4.38M in Q4 2022. 6 funds tracked by Wall St. Rank hold TVGN as of Q4 2023.

W.R. Berkley Corp reported no remaining Tevogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
W.R. Berkley Corp sold 3,975 Tevogen Inc. Common Stock shares in Q4 2023, an estimated $2.15M.
W.R. Berkley Corp first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 5 quarters.
W.R. Berkley Corp's Tevogen Inc. Common Stock position peaked at $4.38M in Q4 2022.
6 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q4 2023.

Based on W.R. Berkley Corp's 13F filing for Q4 2023, filed 14 Feb 2024.